Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 ...

No. 55 / 2026 Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to ...
tradersunion

Eli Lilly advances Foundayo filing after late-stage sleep apnea trial results

Eli Lilly advances Foundayo for sleep apnea after successful late-stage trial data in obese adults. U.S. approval is planned ...